Immunoregulation of Theiler’s virus-induced demyelinating disease by glatiramer acetate without suppression of antiviral immune responses

While most disease-modifying drugs (DMDs) regulate multiple sclerosis (MS) by suppressing inflammation, they can potentially suppress antiviral immunity, causing progressive multifocal leukoencephalopathy (PML). The DMD glatiramer acetate (GA) has been used for MS patients who are at high risk of PM...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arch Virol
Autori principali: Omura, Seiichi, Sato, Fumitaka, Martinez, Nicholas E., Range, Tierra, Ekshyyan, Lesya, Minagar, Alireza, Alexander, J. Steven, Tsunoda, Ikuo
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276114/
https://ncbi.nlm.nih.gov/pubmed/29362931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00705-018-3729-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi